The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWater Intel. Regulatory News (WATR)

Share Price Information for Water Intel. (WATR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 365.00
Bid: 355.00
Ask: 375.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.634%)
Open: 365.00
High: 365.00
Low: 365.00
Prev. Close: 365.00
WATR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Changes

8 Oct 2008 07:00

RNS Number : 3184F
Qonnectis plc
08 October 2008
 

Qonnectis plc ("Qonnectis" or the "Company")

Management Changes

Due to the current ill health of Chief Executive Michael Tapia the Board announces that Guy Chant, currently a Non Executive Director of the Company will act as interim Chief Executive with immediate effect during this period.

Guy has had extensive experience within the European utilities industry, at both senior management and Board levels. Between 1994 and 1999 he was Managing Director of Thames Municipal Products Ltd ("TMP"). Between 2000 and 2004 he was Commercial Director of Thames Water Utilities Ltd and External Affairs Director of Thames Water plc. More recently, Guy was Executive Director at Berlinwasser Holding AG (a joint venture between Land Berlin, RWE/Thames Water ("RWE") and Veolia Environnement S.A.), the main water utility serving the city of Berlin.

The Board is pleased to announce that Barbara Spurrier has been appointed finance director with immediate effect.

Barbara is a qualified certified accountant with over 25 years experience in financial and accountancy roles. She is a founder and Director of Cambridge Equity Partners Ltd., a consultancy business focussing on corporate finance projects, where she has worked with numerous companies to develop strategic business plans and objectives. Barbara has experience in assisting companies to secure capital from institutions and private investors in order to facilitate expansion and development, and has undertaken full business reviews to identify and provide action on key issues.

As previously announced the Company expects to release its preliminary announcement of the results for the year ended 30 June 2008, in November 2008.

Enquiries:

Qonnectis plc 01932 788299 

Guy Chant

Barbara Spurrier

Finncap 0207 600 1658

Clive Carver

Appendix

In accordance with Schedule Two, paragraph (g) of the AIM Rules for Companies, the following information in relation to the appointment of Barbara Spurrier to the Board is disclosed:

Full name: Barbara Joyce Spurrier

Previous names: Barbara Joyce Huxley-Parlour

Barbara Joyce Gagg

Age: 52

Barbara Spurrier currently holds or has held the following directorships and partnerships in the last five years.

Current Directorships and Partnerships

Directorships held in the last five years

Cambridge Equity Partners Ltd.

CBIOS Ltd.

Cambridge Financial Partners LLP

Cellexus Biosystems Inc. 

Cellexus Biosystems Plc.

DCM Incontrol Ltd.

Fair 2 U Ltd.

Freshbourne Ltd 

OxLoc Ltd.

Renewable Energy fuels Worldwide Ltd.

Rototek Ltd

SG32 Ltd

Stribbons Ltd.

TDLP Associates Ltd.

Barbara Spurrier has been a director of the following:

Cellexus Biosystems Plc which was put into administrative receivership on 3 March 2008.

Strathcarron Sports Cars plc which was put into voluntary creditors liquidation on 21 November 2001 with an estimated deficiency as regards creditors of £2,633,000.

J. A. Gagg & Sons Limited which became insolvent under receivership rule 3.32 and was dissolved on 18 November 1997.

There are no further disclosures to be made in relation to Barbara Spurrier pursuant to Schedule Two, paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUBUNRWRRRRAA
Date   Source Headline
9th May 20247:00 amRNSReacquisition and Sale of New Franchise
7th May 20247:00 amRNSChange of Nominated Adviser & Release of Q1 Update
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Feb 20247:00 amRNSFull Year Trading Update
1st Feb 20247:00 amRNSNational Insurance Wins
21st Dec 20237:00 amRNSExpansion of Credit Facility
5th Dec 20237:00 amRNSTrading Update
7th Nov 20237:00 amRNSDirectorate Change
11th Oct 20234:01 pmRNSTR-1: Notification of major holdings
19th Sep 20237:00 amRNSInterim Results
11th Sep 20237:00 amRNSNew Products Update and Notice of Results
26th Jul 202310:55 amRNSResult of AGM
24th Jul 20237:00 amRNSReacquisition of West Covina, California Franchise
7th Jul 20237:00 amRNSIssue of Options
28th Jun 20234:44 pmRNSPosting of Annual Report and Notice of AGM
21st Jun 20237:00 amRNSAudited Results for Year Ended 31 December 2022
10th May 20237:00 amRNSQ1 Trading Update
23rd Feb 20237:00 amRNSTR-1: Standard form notification of major holdings
7th Feb 20237:05 amRNSIssue of Options
7th Feb 20237:00 amRNSTrading Update and Acquisition
17th Nov 20227:00 amRNSTrading Update Q3 2022
22nd Sep 20227:00 amRNSInterim Results
15th Sep 20224:36 pmRNSPrice Monitoring Extension
19th Aug 20223:46 pmRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20225:24 pmRNSExercise of Options
26th Jul 20227:00 amRNSMunicipal Wins in Australia
12th Jul 20227:00 amRNSResult of AGM
16th Jun 20227:00 amRNSAcquisition of Plumbing Company
15th Jun 20224:51 pmRNSPosting of Annual Report and Notice of AGM
9th Jun 20227:00 amRNSAudited Results For Year Ended 31 December 2021
12th May 20227:00 amRNSReacquisition of Central Texas Franchise
9th May 20227:00 amRNSQ1 Trading Update: Accelerating Growth Plan
6th Apr 20228:30 amRNSTransaction in Own Shares and Total Voting Rights
5th Apr 20227:00 amRNS$17 Million Expansion of Credit Facilities
18th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Feb 20227:00 amRNS2021 Trading Results and Operational Highlights
26th Jan 20227:00 amRNSSale of Territory to North Carolina Franchisee
24th Jan 20224:41 pmRNSSecond Price Monitoring Extn
24th Jan 20224:36 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSReacquisition of Fort Worth Franchise
20th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20217:00 amRNSReacquisition of South Oregon Franchise
24th Nov 20217:00 amRNSTR-1: Notification of Major Holdings
24th Nov 20217:00 amRNSPDMR Dealing and Issue of New Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.